跳至主要内容
临床试验/EUCTR2021-002288-24-NL
EUCTR2021-002288-24-NL进行中(未招募)1 期

Effect of citalopram on chest pain in patients with functional chest pain - Ci-FCP

Amsterdam UMC0 个研究点目标入组 52 人开始时间: 2021年7月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Written informed consent
  • Minimum age: 18 years
  • Functional chest pain according to Rome IV criteria
  • Ruled out cardiac origin of chest pain
  • Symptoms of chest pain for at least 6 months
  • Frequency of symptoms at least once a week
  • Gastroduodenoscopy, high-resolution manometry and 24-hour pH-impedance monitoring need to have been performed recently.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 52
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Currently using antidepressants
  • Contraindication for the use of SSRI
  • Already tried antidepressants off-label to treat chest pain
  • Known allergy to citalopram
  • Severe and clinically unstable concomitant disease
  • Pregnant, lactating or fertile women (without contraception)

研究者

发起方
Amsterdam UMC

相似试验